• Symbol:NYSE:HEXO
  • Ticker 2:TSE:HEXO
  • Sector:Healthcare
  • Industry:Pharmaceutical
  • CEO:Sebastien St-Louis
  • Founded:2013

Hexo (NYSE:HEXO) Stock Price

Disclaimer: Past performance is not an indicator of future performance.

Hexo(NYSE:HEXO) Company Overview

HEXO Corp is an award-winning consumer packaged goods cannabis company that creates and distributes prize-winning products to serve the global cannabis market. Through its hub and spoke business strategy, HEXO Corp partners with Fortune 500 companies to deliver its brand value, cannabinoid isolation technology, licensed infrastructure and regulatory expertise to other established companies, leveraging distribution networks and capacity.

As one of the largest licensed cannabis companies in Canada, HEXO Corp operates with 2 million sq. ft of facilities in Ontario and Quebec. The Company is currently establishing its foothold in Greece to establish a Eurozone for processing, production and distribution of cannabis products.

Incorporated in 2013 under the name The Hydropothecary Corporation, the company was initially created to meet the needs of the Canadian medical cannabis market. With the advent of the legalized market in 2018, the company became HEXO Corp, for both adult-use (recreational) and medical markets.

Investor Presentation

The latest update from the company

Click Here
Stay updated about
this company

Become a Patron below and support us in covering the latest marijuana news!